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Abstract
Background: This case report is interesting as cases of children with laryngeal inflammatory myofibroblastic tumor
are not common and previously had been presented as isolated case reports. This is the first case report in Asia
describing a laryngeal inflammatory myofibroblastic tumor and its removal using an endoscopic approach.
Case presentation: Our patient is a 12-year-old Malay girl from Singapore who presented with hoarseness without
respiratory distress. The initial impression was that of a granuloma or a papilloma. We did a biopsy, which
confirmed the histology to be inflammatory myofibroblastic tumor, and a magnetic resonance imaging scan
showed a contrast-enhanced lesion. The lesion was excised completely using an endoscopic approach. The child
was discharged well on the first postoperative day and she has been on follow-up for a year in the clinic.
Conclusions: This report highlights the importance of understanding the differential diagnosis for a child with
hoarseness. It is not uncommon for a pediatrician, a general practitioner, and a pediatric otolaryngologist to see a
child presenting with hoarseness. In most cases, the diagnosis made would be screamer’s nodules, which is
commonly seen in children. In a small group, recurrent respiratory papillomatosis form the diagnosis. Over the past
few years, the cases of recurrent respiratory papillomatosis have decreased significantly. Laryngeal tumors are not
common in children. However, we must maintain a high index of suspicion when we have a child with hoarseness
who does not improve with speech therapy and watchful waiting. In such situations, a stroboscope is usually
necessary to diagnose the voice problems and to rule out pathological conditions such as laryngeal tumors. If left
untreated, the lesion can grow with time and result in a life-threatening airway condition. We also demonstrate our
endoscopic technique in this report, and it has proven to be safe with no increased recurrence and much lower
morbidity.
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Background
Inflammatory myofibroblastic tumors (IMT) are rare tu-
mors that have a wide spectrum of histological features
ranging from plasma cell-rich lesions to myofibroblast-
predominant lesions. These lesions are frequently found
in the lung but similar lesions have been reported in extra-
pulmonary sites such as the genitourinary tract, gastro-
intestinal tract, the breast, salivary glands, sinonasal tract,
orbit, and the central nervous system. Laryngeal involve-
ment of IMT is very rare. The largest case series of
eight cases of laryngeal IMT was reported by Wenig
et al. in 1995 [1].
IMT are rare benign tumors. They are also known as
plasma cell granuloma. Although benign in nature, they
tend to be locally aggressive and it is not uncommon for
local invasion and recurrences to occur [2]. Complete
excision has been the mainstay of treatment.
Laryngeal IMT has been reported in the pediatric popu-
lation previously. However, they were mainly isolated
cases. We present our unusual case of IMT in a 12-year-
old Malay girl who presented to us with hoarseness with
no airway issues.* Correspondence: sok_yan_tay@nuhs.edu.sg
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Case presentation
Our patient was a 12-year-old Malay girl from Singapore
who presented to our clinic with the complaint of
hoarseness for a duration of 9 months after a sore
throat. Prior to that she was well. Unlike the typical
presentation in recurrent respiratory papillomatosis,
when the child tends to present earlier, at the age of 4 or
5 years old, her onset of hoarseness started only when
she was 12 years old. It was progressively worsening.
Fortunately, she did not have any associated airway is-
sues. She was able to eat and drink normally and there
was no suggestion of recent weight loss. The risk factors
for hoarseness such as vocal abuse, talking, and singing
loudly were also not present in her case. There was no
significant family history of note.
A perceptual evaluation of voice quality using GRBAS
(Grade, Roughness, Breathiness, Asthenia, and Strain)
was performed. She was given a score of G: 3 R: 3 B: 0
A: 3 S: 1.
Her only complaint was hoarseness. She was otherwise
well. There were no signs of airway distress and no feed-
ing issues. Her growth centile was appropriate for her
age. There was no family history of similar disease. We
performed a flexible nasoendoscopy on her. There was a
lesion seen on her right vocal cord as shown in the
picture (Fig. 1). This lesion was well circumscribed with
a smooth mucosal surface. There were no other abnor-
malities. Her vocal cord movements were normal.
At that time, our working diagnosis for her included
vocal cord polyp, granuloma, and recurrent respiratory
papilloma.
Our patient was brought to the operating theater
where she underwent microlaryngoscopy and bron-
choscopy (MLB). Intraoperatively, there was a large
broad-based lesion involving the anterior two-thirds of
her right true vocal cords and ventricle. The lesion was
firm on palpation. Her left vocal cord was normal
(Fig. 2). A biopsy was taken and sent for histology.
Pathological analysis of the lesion revealed chronic in-
flammation with stromal myxoid degeneration and hya-
linization (Figs. 3 and 4).
In view of the unusual location and presentation of the
lesion, we decided to perform a magnetic resonance im-
aging (MRI) scan of her neck. The MRI scan showed a 1.5
× 1.6 × 1.7 cm heterogeneous submucosal solid lesion,
isointense to hypointense on T1, and hyperintense on T2,
with avid enhancement post contrast administration in
the ventricular region on the right side (Figs. 5, 6 and 7).
We proceeded to perform a complete excision of the
lesion. We used the monopolar diathermy to define the
excision margin. A laryngeal microdebrider was used to
remove the lesion with endoscope assistance (Fig. 8).
The child was monitored overnight in the hospital and
was discharged home the following day.
The final pathologic analysis suggested the possible
diagnosis of IMT.
Histopathology of the biopsy samples (Figs. 3 and 4)
revealed myxoid changes and associated atypical-
appearing cells characterized by ovoid to spindle-shaped
cells with enlarged vesicular to hyperchromatic nuclei
but still with an ample amount of eosinophilic to slightly
basophilic-appearing cytoplasm, as well as associated
Fig. 1 Pre-operatively, lesion on the right vocal cord as seen on
flexible nasoendoscopy
Fig. 2 Intra-operatively, lesion seen on the anterior two thirds of the
right true vocal cords and ventricle
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multinucleated cells. These features were suggestive of
an inflammatory myofibroblastic tumor (IMT).
Immunohistochemical staining showed these cells to
have weak reactivity for smooth muscle actin and
muscle-specific actin but negative for ALK1, desmin,
and S100 protein. A low proliferation rate of less than
5 % was seen by Ki67 staining. CD68 was positive in
scattered inflammatory cells but not the atypical cells.
Following the excision, our patient was reviewed in
the clinic. At 2.5 months post surgery, her voice has im-
proved. There was a small nodule seen on her right
vocal cord (Fig. 9). Our patient and her family were not
keen to have repeat surgery for removal of the nodule in
view of the symptom improvements. Four months later,
she was reviewed again in the clinic. Her voice contin-
ued to improve and the previously seen nodule has dis-
appeared (Fig. 10). We postulated that the nodule could
have been a result of incorrect vocal usage post surgery
and not related to the original IMT. She is currently on
regular follow-up and will be returning 6 monthly for re-
view. Her last review was about a year post surgery;
there has been no recurrence of the lesion (Fig. 11).
Discussion
Inflammatory myofibroblastic tumors (IMT) are benign
lesions that mimic neoplastic lesions. To date, 39 cases
of laryngeal IMT have been described in the English
Fig. 3 Myxoid tumour composed of ovoid to spindle shaped cells
with associated plasma cells (H & E, magnification x 200)
Fig. 4 Cells demonstrating vesicular to hyperchromatic nuclei with
ample eosinophilic to lightly basophilic cytoplasm (H & E,
magnification x 400)
Fig. 5 Coronal T2 image showing hyperintense lesion
Fig. 6 Axial T1 image showing isointense to hypointense lesion
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literature. The mean age of disease presentation was
44.5 years with a range of 2 to 74 years old [3]. Coffin et
al. reported 84 extrapulmonary cases of IMT in a group
of patients ranging from 3 months to 46 years and in
this study only three out of the 84 patients had laryngeal
IMT and they were all pediatric cases. The larynx is an
uncommon site for IMT to occur [4].
IMT have been previously reported under a variety of
names such as plasma cell granuloma, histiocytoma, plasma
cell histiocytoma complex, inflammatory fibrosarcoma, and
benign myofibroblastoma. However, since 1994, based on
the World Health Organization (WHO) guidelines, the ter-
minology inflammatory myofibroblastic tumor (IMT) has
been used to describe these lesions [5]. IMT are character-
ized by myofibroblastic spindle cells on a background of
inflammatory cells. Based on Coffin’s classification, it can
be divided into three main categories: (1) hypocellular, (2)
hypercellular, and (3) collagen sheets pattern. In this first
type, the myofibroblasts are organized loosely within a
background of inflammatory cells such as plasma cells,
lymphocytes, and eosinophils. The second type are
densely aggregated, elongated, short spindle cells or stel-
late cells arranged on a collagenized background, and in
the third type, the cellular component is loosely arranged,
resembling scar tissue [5–7]. Immunohistochemical
Fig. 7 Axial T1 image with contrast showing lesion with
avid enhancement
Fig. 8 Post excision of the lesion
Fig. 9 Nodule on the right vocal cord
Fig. 10 4 months later, previously seen nodule resolved
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staining often plays an important role in the diagnosis of la-
ryngeal IMT. Muscle-specific actin, vimentin, and smooth
muscle actin are often present in IMT. Occasionally, des-
min and cytokeratins can be stained positive as well [8].
A child with IMT often presents with similar symp-
toms as patients with other laryngeal lesions. Hoarseness
is the most common complaint. Other symptoms in-
clude that of dysphagia, failure to thrive, dyspnea, or
stridor. The differential diagnosis to consider in a child
who present with hoarseness would include that of re-
current respiratory papillomatosis, vocal cord polyp, and
granulomatous lesion [9]. The appearance of IMT on
endoscopy has been described as a smooth surface,
polypoid or pedunculated lesion, firm and fleshy in na-
ture. The size of which can range from several millime-
ters to 6 cm [1, 10].
The true causative factor leading to the development of
laryngeal IMT remains unknown. Many theories have
been proposed and these include trauma, infections, neo-
plasm, and immunological factors. Smoking has been sug-
gested as a risk factor, as 22.6 % of the patients with
laryngeal IMT were smokers. Epstein–Barr virus (EBV)
has been shown to be associated with IMT at extralaryn-
geal sites but not in the larynx [8, 11]. The neoplastic the-
ory has been suggested because of tumor recurrence and
malignant progression seen in cases of IMT. Anaplastic
lymphoma kinase 1 (ALK 1), chromosomal rearrangement
at chromosome 2p23 and p80, have been suggested to be
associated with the neoplastic theory [12].
Laryngeal IMT occurs most commonly in the true vocal
cords, followed by the subglottis. Rarely, do they occur in
the supraglottis [13]. The presentation complaints vary de-
pending on the site of the lesion. In our case and similar to
previous case series, voice change is the most common
presentation (74 %), followed by stridor (29 %) and dyspnea,
shortness of breath (22.5 %), and globus sensation (16 %).
Prior to surgery, radiological investigations such as
computed tomography (CT) scans and magnetic reson-
ance imaging (MRI) are usually performed to determine
the extent of the lesion. An MLB with biopsy and immu-
nohistochemical staining of the lesion is often necessary
for diagnosis. Surgical excision with good margins is the
treatment of choice for this disease. This can be done
using an endoscopic technique or an open technique.
Endoscopic excision using laser or cold steel instruments
is the preferred technique. Open technique is commonly
reserved for recurrent cases, cases with poor visualization
using endoscope or when malignancy cannot be excluded.
We used the endoscopic technique in this case and were
able to excise the lesion completely. The advantages of
adopting the endoscopic technique were lesser postopera-
tive pain, faster recovery, shorter hospital stay, and better
voice outcome. The exposure from the endoscope was ad-
equate for us to visualize the entire lesion and to perform
a complete excision. However, as this is our first case, we
are still following up this patient closely. At 1 year post
surgery, our patient is still disease-free without any
recurrence.
Radiotherapy is used mainly to treat local recurrence.
The use of chemotherapy is also limited to the treatment
of lesion that has undergone malignant transformation
or recurrent IMT. Steroid has been used on its own and
also as an adjunct with surgery. Steroid as a sole therapy
seems to be less effective. However, in a patient with se-
vere comorbidity and surgery carries a high risk, or
when the surgery will result in significant function loss,
a course of pulsed steroids can be attempted.
The main factors leading to recurrence of disease is
often partial/incomplete excision of tumor. The recur-
rence rate of laryngeal IMT is 8 to 18 % [9, 14]. The re-
currence occurs most commonly within 2 to 12 months.
In some patients with multiple recurrences, a laryngec-
tomy may have to be considered. We are pleased that
our patient has been disease-free throughout the follow-
up at the time of submission.
Conclusions
Inflammatory myofibroblastic tumor is an unusual tumor
that can mimic a neoplastic process. Many etiologies have
been proposed but none has been proven. Immunohisto-
chemical staining plays an important role in the histo-
logical diagnosis of IMT. The initial presentation of IMT
in a child is most often hoarseness. It is important to ex-
clude laryngeal lesion as a cause of persistent hoarseness
in a child. This can be done with the use of a nasoendo-
scopy. A delay in diagnosis of a laryngeal lesion can result
in a life-threatening airway issue. The treatment of choice
Fig. 11 Last follow up picture showing no recurrence of the lesion
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for IMT remains surgical excision with good margins. The
endoscopic approach used in this case results in less post-
operative morbidity with no increased recurrence. Good
postoperative follow-up is necessary in order to detect any
recurrence promptly.
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